Literature DB >> 10803885

Antimycin A resistance in a mutant Leishmania tarentolae strain is correlated to a point mutation in the mitochondrial apocytochrome b gene.

A Schnaufer1, S Sbicego, B Blum.   

Abstract

In this paper we report the first case of antimycin A resistance in a protozoan parasite that is attributable to a mutation in the mitochondrial apocytochrome b (CYb) gene. We selected for, and isolated, a mutant Leishmania tarentolae strain that is resistant to antimycin A. This resistance was evident at the levels of the in vitro growth and enzymatic activity of the cytochrome bc1 complex. Molecular characterisation of the mutant revealed a Ser35Ile mutation in the expected region of the CYb gene. In kinetoplastids, CYb and other structural genes of the mitochondrial genome are located on the maxicircle component of the mitochondrial DNA, which is present in 20-50 copies. Primer-extension analysis confirmed the presence of the mutation at the mRNA level. The phenotypic manifestation of the mutation implies that the CYb mRNA is edited and translated within the mitochondrion. Thus, this finding provides direct evidence that edited RNAs are translated in kinetoplastid mitochondria. Furthermore, a defined mutation conferring drug resistance to a mitochondrial gene product can be exploited for the development of mitochondrial transfection systems for trypanosomatids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803885     DOI: 10.1007/s002940050525

Source DB:  PubMed          Journal:  Curr Genet        ISSN: 0172-8083            Impact factor:   3.886


  9 in total

Review 1.  Unexplained complexity of the mitochondrial genome and transcriptome in kinetoplastid flagellates.

Authors:  Julius Lukes; Hassan Hashimi; Alena Zíková
Journal:  Curr Genet       Date:  2005-11-04       Impact factor: 3.886

2.  Crystal structure of bacterial cytochrome bc 1 in complex with azoxystrobin reveals a conformational switch of the Rieske iron-sulfur protein subunit.

Authors:  Lothar Esser; Fei Zhou; Chang-An Yu; Di Xia
Journal:  J Biol Chem       Date:  2019-06-10       Impact factor: 5.157

3.  A novel mutation in the mitochondrial DNA cytochrome b gene (MTCYB) in a patient with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes syndrome.

Authors:  Valentina Emmanuele; Evangelia Sotiriou; Purificación Gutierrez Rios; Jaya Ganesh; Rebecca Ichord; A Reghan Foley; H Orhan Akman; Salvatore Dimauro
Journal:  J Child Neurol       Date:  2012-05-25       Impact factor: 1.987

4.  Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex: a new crystal structure reveals an altered intramolecular hydrogen-bonding pattern.

Authors:  Li-Shar Huang; David Cobessi; Eric Y Tung; Edward A Berry
Journal:  J Mol Biol       Date:  2005-08-19       Impact factor: 5.469

Review 5.  Structural basis of resistance to anti-cytochrome bc₁ complex inhibitors: implication for drug improvement.

Authors:  Lothar Esser; Chang-An Yu; Di Xia
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  Structural and functional association of Trypanosoma brucei MIX protein with cytochrome c oxidase complex.

Authors:  Alena Zíková; Aswini K Panigrahi; Alessandro D Uboldi; Rachel A Dalley; Emanuela Handman; Kenneth Stuart
Journal:  Eukaryot Cell       Date:  2008-09-05

7.  Development of a semi-automated image-based high-throughput drug screening system.

Authors:  Remzi Onur Eren; Dmitry Kopelyanskiy; Dimitri Moreau; Julien Bortoli Chapalay; Marc Chambon; Gerardo Turcatti; Lon-Fye Lye; Stephen M Beverley; Nicolas Fasel
Journal:  Front Biosci (Elite Ed)       Date:  2018-01-01

8.  Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy.

Authors:  Alicia Ponte-Sucre
Journal:  Kinetoplastid Biol Dis       Date:  2003-10-28

9.  Structural analysis of mitochondrial mutations reveals a role for bigenomic protein interactions in human disease.

Authors:  Rhiannon E Lloyd; John E McGeehan
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.